Waters Parkerson & Co., LLC Coll Plant Biotechnologies LTD Transaction History
Waters Parkerson & Co., LLC
- $1.81 Billion
- Q1 2025
A detailed history of Waters Parkerson & Co., LLC transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Waters Parkerson & Co., LLC holds 13,250 shares of CLGN stock, worth $18,417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,250Holding current value
$18,417% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLGN
# of Institutions
19Shares Held
2.07MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD489KShares$679,9780.02% of portfolio
-
Villere St Denis J & CO LLC484KShares$672,5750.13% of portfolio
-
Investment Management Of Virginia LLC464KShares$644,8190.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$384,2372.69% of portfolio
-
Amh Equity LTD125KShares$173,7500.52% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $15.4M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...